Sandur Manganese & Iron Ores Ltd reports Q2 consolidated net profit of ₹261.25 crore, up 88.1% year on year
- Consolidated revenue rose 22.2% year on year to ₹1,506.13 crore; estimated operating EBITDA margin was 25.1%.
- Board approved investment of up to ₹200 crore in Royal Sandur MedTech.
- G. P. Kundargi was appointed non-executive director, subject to shareholder approval; Dr. Latha Pillai’s resignation takes effect 4 November 2026.
- Results included a ₹9.32 crore exceptional-item reversal; the auditor’s limited-review conclusion was unmodified.